withdrawal symptom

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.withdrawal symptom - any physical or psychological disturbance (as sweating or depression) experienced by a drug addict when deprived of the drug
symptom - (medicine) any sensation or change in bodily function that is experienced by a patient and is associated with a particular disease
References in periodicals archive ?
The most common caffeine withdrawal symptom you'll have is (https://draxe.com/health/brain-health/caffeine-headaches/) headache .
When you drink to overcome a withdrawal symptom, then this is a big red flag.
The tool was evaluated for the utility of each withdrawal symptom to determine duplication of similar items and redundant, non-specific, or difficult items were dropped.
Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
The woman reported a nagging withdrawal symptom - a dry, salty taste in her mouth - that was alleviated by the persistent drinking of water (up to 60 glasses per day).
YOU I stopped three weeks ago, having smoked for 35 years, after reading Allen Carr's book Easy Way, and I've had no cravings or withdrawal symptoms.
Your reader obviously stopped through willpower, which I'm impressed by but it must have been hell having withdrawal symptoms for two years.
[USA], July 26 (ANI): Almost a month after he began shooting for his upcoming project 'Gulabo Sitabo' in Lucknow, Amitabh Bachchan is dealing with 'withdrawal symptoms' as the movie schedule wrap nears its completion.
Patients seeking treatment for depression should be informed of the potential for "severe and long-lasting withdrawal symptoms" when coming off medication.
Often associated with illegal drugs and other addictive substances, withdrawal or withdrawal symptoms refer to the body's reaction to a sudden and drastic reduction in intake of the substances.
BioXcel Therapeutics announced proof-of-concept data from its Phase 1b study of intravenously-administered dexmedetomidine in patients suffering from opioid withdrawal symptoms. The positive data from this Phase 1b trial provides evidence to expand the potential market for BXCL501, a proprietary sublingual film of Dex, beyond its current focus for acute treatment of agitation in neuropsychiatric indications.